Screener
Neuropace, Inc. NPCE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
| (in thousands, except for share and per share amounts) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $12,538 | $21,692 |
| Short-term investments | 39,161 | 39,366 |
| Accounts receivable | 14,930 | 12,936 |
| Inventory | 18,111 | 14,862 |
| Prepaid expenses and other current assets | 1,453 | 1,438 |
| Current assets of discontinued operations | — | 3,779 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Neuropace, Inc.'s short-term investments?
- Neuropace, Inc. (NPCE) reported short-term investments of $39.16M in Q2 2026.
- How has Neuropace, Inc.'s short-term investments changed year-over-year?
- Neuropace, Inc.'s short-term investments decreased by 0.3% year-over-year, from $39.28M to $39.16M.
- What is the long-term trend for Neuropace, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s short-term investments has grown at a 27.5% compound annual growth rate (CAGR), from $11.69M to $39.37M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Neuropace, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude